Who owns K-V Pharmaceutical Company?

Key details on K-V Pharmaceutical Company (Ticker: KV.B)

Who owns K-V Pharmaceutical Company?

Is KV.B a good stock to own? Find out who bought K-V Pharmaceutical Company, who sold K-V Pharmaceutical Company (KV.B) stock, and who holds a large position in K-V Pharmaceutical Company.

Fund Name Number of Shares Share Valuation As Of
GOLDMAN SACHS 85790 $72063 June 30, 2012
Oppenheimer & Co 78312 $65782 June 30, 2012
TSP Capital Management 56928 $47819 June 30, 2012
Nomura Holdings 770 $0 June 30, 2012
UBS AG 363 $500 March 31, 2012
Wells Fargo & Company 337 $0 June 30, 2012

Who sold K-V Pharmaceutical Company?

Fund Name Date Sold Number of Shares Sold Share Valuation
Renaissance Technologies March 31, 2011 13100 $77945
Barclays March 31, 2011 977 $5998